SAMHD1 and cancer: Owing to its dNTPase activity, SAMHD1 may serve as an intriguing target of cancer therapy as reduction of dNTP pool may prevent tumorigenesis or an increase in efficacy of anti-nucleotide chemotherapeutics (Fig. 1).